Loading…
10-Fold increase (2006-11) in the rate of healthy subjects with extended-spectrum -lactamase-producing Escherichia coli faecal carriage in a Parisian check-up centre
In 2006, 0.6% of healthy subjects living in the Paris area had extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in their gut. To assess the evolution of this rate, a study identical to that of 2006 was conducted in 2011. Healthy adults who visited the IPC check-up centre in February-M...
Saved in:
Published in: | Journal of antimicrobial chemotherapy 2013-03, Vol.68 (3), p.562-568 |
---|---|
Main Authors: | , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c222t-b21a4a7c3df5ef2bb887f63fd6624ccd3b984178b1c82386774b14c0ac66dca13 |
---|---|
cites | cdi_FETCH-LOGICAL-c222t-b21a4a7c3df5ef2bb887f63fd6624ccd3b984178b1c82386774b14c0ac66dca13 |
container_end_page | 568 |
container_issue | 3 |
container_start_page | 562 |
container_title | Journal of antimicrobial chemotherapy |
container_volume | 68 |
creator | Nicolas-Chanoine, M.-H. Gruson, C. Bialek-Davenet, S. Bertrand, X. Thomas-Jean, F. Bert, F. Moyat, M. Meiller, E. Marcon, E. Danchin, N. Noussair, L. Moreau, R. Leflon-Guibout, V. |
description | In 2006, 0.6% of healthy subjects living in the Paris area had extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in their gut. To assess the evolution of this rate, a study identical to that of 2006 was conducted in 2011. Healthy adults who visited the IPC check-up centre in February-March 2011 and agreed to participate, provided stools and answered a questionnaire on the visit day. Stools were analysed to detect ESBL producers and to isolate the dominant E. coli population. ESBLs were molecularly characterized. For the subjects harbouring ESBL-producing E. coli, the phylogenetic group and sequence type (ST) were determined for both ESBL-producing and dominant E. coli isolates. PFGE profiles were also determined when two types of isolates had the same ST. Among the 345 subjects included, 21 (6%) had ESBL-producing E. coli faecal carriage. None of the previously published risk factors was identified. CTX-M accounted for 86% and SHV-12 for 14%. Dominant and ESBL-producing E. coli were similarly distributed into phylogenetic groups (A, 52%-48%; B1, 5%; B2, 24%-14%; and D, 19%-33%). Dominant and ESBL-producing E. coli displayed a polyclonal structure (18 STs each). However, ST10 and ST131 were identified in dominant and ESBL-producing E. coli isolates from different subjects. Most (20/21) ESBL producers were subdominant and belonged (16/21) to STs different from that of the corresponding dominant E. coli. The 10-fold increase in the rate of healthy subjects with ESBL-producing E. coli faecal carriage over a 5 year period suggests wide dissemination of these isolates in the Parisian community. |
doi_str_mv | 10.1093/jac/dks429 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1318695924</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1318695924</sourcerecordid><originalsourceid>FETCH-LOGICAL-c222t-b21a4a7c3df5ef2bb887f63fd6624ccd3b984178b1c82386774b14c0ac66dca13</originalsourceid><addsrcrecordid>eNpdkc1u1TAQhS1EJS6XbngCS2wKkql_EsdZoqqlSJVgQdfRZDxpfJubXGxHbd-GXd-DJ8PVZcVqpDOfzhzNYey9kp-VbM35DvDc36dKt6_YRlVWCi1b9ZptpJG1aKravGFvU9pJKW1t3YY9KymulsnzMGMkSMTPdNkJpT4WieeReIRMfBn4SDDl8Ymntd8R5sQfQh45PWaaPXmRDkWM657_-S0mwAz74iYOcfErhvmOXyYcKQYcA3BcpsAHIISJI8QY4I5ezgH_ATGkADMvMN6L9cCR5hzpHTsZYEp0-m9u2e3V5c-La3Hz_eu3iy83ArXWWfRaQQUNGj_UNOi-d64ZrBm8tbpC9KZvXaUa1yt02jjbNFWvKpSA1noEZbbs7Ohbgv9aKeVuHxLSNMFMy5o6ZZSzbd3qqqAf_kN3yxrnkq5T2tW6aUz595Z9OlIYl5QiDd0hhj3Ep07J7qWzrnTWHTszfwE9IIvj</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1285277345</pqid></control><display><type>article</type><title>10-Fold increase (2006-11) in the rate of healthy subjects with extended-spectrum -lactamase-producing Escherichia coli faecal carriage in a Parisian check-up centre</title><source>Oxford Journals Online</source><creator>Nicolas-Chanoine, M.-H. ; Gruson, C. ; Bialek-Davenet, S. ; Bertrand, X. ; Thomas-Jean, F. ; Bert, F. ; Moyat, M. ; Meiller, E. ; Marcon, E. ; Danchin, N. ; Noussair, L. ; Moreau, R. ; Leflon-Guibout, V.</creator><creatorcontrib>Nicolas-Chanoine, M.-H. ; Gruson, C. ; Bialek-Davenet, S. ; Bertrand, X. ; Thomas-Jean, F. ; Bert, F. ; Moyat, M. ; Meiller, E. ; Marcon, E. ; Danchin, N. ; Noussair, L. ; Moreau, R. ; Leflon-Guibout, V.</creatorcontrib><description>In 2006, 0.6% of healthy subjects living in the Paris area had extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in their gut. To assess the evolution of this rate, a study identical to that of 2006 was conducted in 2011. Healthy adults who visited the IPC check-up centre in February-March 2011 and agreed to participate, provided stools and answered a questionnaire on the visit day. Stools were analysed to detect ESBL producers and to isolate the dominant E. coli population. ESBLs were molecularly characterized. For the subjects harbouring ESBL-producing E. coli, the phylogenetic group and sequence type (ST) were determined for both ESBL-producing and dominant E. coli isolates. PFGE profiles were also determined when two types of isolates had the same ST. Among the 345 subjects included, 21 (6%) had ESBL-producing E. coli faecal carriage. None of the previously published risk factors was identified. CTX-M accounted for 86% and SHV-12 for 14%. Dominant and ESBL-producing E. coli were similarly distributed into phylogenetic groups (A, 52%-48%; B1, 5%; B2, 24%-14%; and D, 19%-33%). Dominant and ESBL-producing E. coli displayed a polyclonal structure (18 STs each). However, ST10 and ST131 were identified in dominant and ESBL-producing E. coli isolates from different subjects. Most (20/21) ESBL producers were subdominant and belonged (16/21) to STs different from that of the corresponding dominant E. coli. The 10-fold increase in the rate of healthy subjects with ESBL-producing E. coli faecal carriage over a 5 year period suggests wide dissemination of these isolates in the Parisian community.</description><identifier>ISSN: 0305-7453</identifier><identifier>EISSN: 1460-2091</identifier><identifier>DOI: 10.1093/jac/dks429</identifier><language>eng</language><publisher>Oxford: Oxford Publishing Limited (England)</publisher><subject>Bacterial infections ; beta -Lactamase ; Digestive tract ; E coli ; Enzymes ; Escherichia coli ; Evolution ; Feces ; Inventories ; Phylogenetics ; Phylogeny ; Polyclonal antibodies ; Risk factors</subject><ispartof>Journal of antimicrobial chemotherapy, 2013-03, Vol.68 (3), p.562-568</ispartof><rights>Copyright Oxford Publishing Limited(England) Mar 2013</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c222t-b21a4a7c3df5ef2bb887f63fd6624ccd3b984178b1c82386774b14c0ac66dca13</citedby><cites>FETCH-LOGICAL-c222t-b21a4a7c3df5ef2bb887f63fd6624ccd3b984178b1c82386774b14c0ac66dca13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Nicolas-Chanoine, M.-H.</creatorcontrib><creatorcontrib>Gruson, C.</creatorcontrib><creatorcontrib>Bialek-Davenet, S.</creatorcontrib><creatorcontrib>Bertrand, X.</creatorcontrib><creatorcontrib>Thomas-Jean, F.</creatorcontrib><creatorcontrib>Bert, F.</creatorcontrib><creatorcontrib>Moyat, M.</creatorcontrib><creatorcontrib>Meiller, E.</creatorcontrib><creatorcontrib>Marcon, E.</creatorcontrib><creatorcontrib>Danchin, N.</creatorcontrib><creatorcontrib>Noussair, L.</creatorcontrib><creatorcontrib>Moreau, R.</creatorcontrib><creatorcontrib>Leflon-Guibout, V.</creatorcontrib><title>10-Fold increase (2006-11) in the rate of healthy subjects with extended-spectrum -lactamase-producing Escherichia coli faecal carriage in a Parisian check-up centre</title><title>Journal of antimicrobial chemotherapy</title><description>In 2006, 0.6% of healthy subjects living in the Paris area had extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in their gut. To assess the evolution of this rate, a study identical to that of 2006 was conducted in 2011. Healthy adults who visited the IPC check-up centre in February-March 2011 and agreed to participate, provided stools and answered a questionnaire on the visit day. Stools were analysed to detect ESBL producers and to isolate the dominant E. coli population. ESBLs were molecularly characterized. For the subjects harbouring ESBL-producing E. coli, the phylogenetic group and sequence type (ST) were determined for both ESBL-producing and dominant E. coli isolates. PFGE profiles were also determined when two types of isolates had the same ST. Among the 345 subjects included, 21 (6%) had ESBL-producing E. coli faecal carriage. None of the previously published risk factors was identified. CTX-M accounted for 86% and SHV-12 for 14%. Dominant and ESBL-producing E. coli were similarly distributed into phylogenetic groups (A, 52%-48%; B1, 5%; B2, 24%-14%; and D, 19%-33%). Dominant and ESBL-producing E. coli displayed a polyclonal structure (18 STs each). However, ST10 and ST131 were identified in dominant and ESBL-producing E. coli isolates from different subjects. Most (20/21) ESBL producers were subdominant and belonged (16/21) to STs different from that of the corresponding dominant E. coli. The 10-fold increase in the rate of healthy subjects with ESBL-producing E. coli faecal carriage over a 5 year period suggests wide dissemination of these isolates in the Parisian community.</description><subject>Bacterial infections</subject><subject>beta -Lactamase</subject><subject>Digestive tract</subject><subject>E coli</subject><subject>Enzymes</subject><subject>Escherichia coli</subject><subject>Evolution</subject><subject>Feces</subject><subject>Inventories</subject><subject>Phylogenetics</subject><subject>Phylogeny</subject><subject>Polyclonal antibodies</subject><subject>Risk factors</subject><issn>0305-7453</issn><issn>1460-2091</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNpdkc1u1TAQhS1EJS6XbngCS2wKkql_EsdZoqqlSJVgQdfRZDxpfJubXGxHbd-GXd-DJ8PVZcVqpDOfzhzNYey9kp-VbM35DvDc36dKt6_YRlVWCi1b9ZptpJG1aKravGFvU9pJKW1t3YY9KymulsnzMGMkSMTPdNkJpT4WieeReIRMfBn4SDDl8Ymntd8R5sQfQh45PWaaPXmRDkWM657_-S0mwAz74iYOcfErhvmOXyYcKQYcA3BcpsAHIISJI8QY4I5ezgH_ATGkADMvMN6L9cCR5hzpHTsZYEp0-m9u2e3V5c-La3Hz_eu3iy83ArXWWfRaQQUNGj_UNOi-d64ZrBm8tbpC9KZvXaUa1yt02jjbNFWvKpSA1noEZbbs7Ohbgv9aKeVuHxLSNMFMy5o6ZZSzbd3qqqAf_kN3yxrnkq5T2tW6aUz595Z9OlIYl5QiDd0hhj3Ep07J7qWzrnTWHTszfwE9IIvj</recordid><startdate>20130301</startdate><enddate>20130301</enddate><creator>Nicolas-Chanoine, M.-H.</creator><creator>Gruson, C.</creator><creator>Bialek-Davenet, S.</creator><creator>Bertrand, X.</creator><creator>Thomas-Jean, F.</creator><creator>Bert, F.</creator><creator>Moyat, M.</creator><creator>Meiller, E.</creator><creator>Marcon, E.</creator><creator>Danchin, N.</creator><creator>Noussair, L.</creator><creator>Moreau, R.</creator><creator>Leflon-Guibout, V.</creator><general>Oxford Publishing Limited (England)</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>P64</scope></search><sort><creationdate>20130301</creationdate><title>10-Fold increase (2006-11) in the rate of healthy subjects with extended-spectrum -lactamase-producing Escherichia coli faecal carriage in a Parisian check-up centre</title><author>Nicolas-Chanoine, M.-H. ; Gruson, C. ; Bialek-Davenet, S. ; Bertrand, X. ; Thomas-Jean, F. ; Bert, F. ; Moyat, M. ; Meiller, E. ; Marcon, E. ; Danchin, N. ; Noussair, L. ; Moreau, R. ; Leflon-Guibout, V.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c222t-b21a4a7c3df5ef2bb887f63fd6624ccd3b984178b1c82386774b14c0ac66dca13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Bacterial infections</topic><topic>beta -Lactamase</topic><topic>Digestive tract</topic><topic>E coli</topic><topic>Enzymes</topic><topic>Escherichia coli</topic><topic>Evolution</topic><topic>Feces</topic><topic>Inventories</topic><topic>Phylogenetics</topic><topic>Phylogeny</topic><topic>Polyclonal antibodies</topic><topic>Risk factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nicolas-Chanoine, M.-H.</creatorcontrib><creatorcontrib>Gruson, C.</creatorcontrib><creatorcontrib>Bialek-Davenet, S.</creatorcontrib><creatorcontrib>Bertrand, X.</creatorcontrib><creatorcontrib>Thomas-Jean, F.</creatorcontrib><creatorcontrib>Bert, F.</creatorcontrib><creatorcontrib>Moyat, M.</creatorcontrib><creatorcontrib>Meiller, E.</creatorcontrib><creatorcontrib>Marcon, E.</creatorcontrib><creatorcontrib>Danchin, N.</creatorcontrib><creatorcontrib>Noussair, L.</creatorcontrib><creatorcontrib>Moreau, R.</creatorcontrib><creatorcontrib>Leflon-Guibout, V.</creatorcontrib><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Journal of antimicrobial chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nicolas-Chanoine, M.-H.</au><au>Gruson, C.</au><au>Bialek-Davenet, S.</au><au>Bertrand, X.</au><au>Thomas-Jean, F.</au><au>Bert, F.</au><au>Moyat, M.</au><au>Meiller, E.</au><au>Marcon, E.</au><au>Danchin, N.</au><au>Noussair, L.</au><au>Moreau, R.</au><au>Leflon-Guibout, V.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>10-Fold increase (2006-11) in the rate of healthy subjects with extended-spectrum -lactamase-producing Escherichia coli faecal carriage in a Parisian check-up centre</atitle><jtitle>Journal of antimicrobial chemotherapy</jtitle><date>2013-03-01</date><risdate>2013</risdate><volume>68</volume><issue>3</issue><spage>562</spage><epage>568</epage><pages>562-568</pages><issn>0305-7453</issn><eissn>1460-2091</eissn><abstract>In 2006, 0.6% of healthy subjects living in the Paris area had extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in their gut. To assess the evolution of this rate, a study identical to that of 2006 was conducted in 2011. Healthy adults who visited the IPC check-up centre in February-March 2011 and agreed to participate, provided stools and answered a questionnaire on the visit day. Stools were analysed to detect ESBL producers and to isolate the dominant E. coli population. ESBLs were molecularly characterized. For the subjects harbouring ESBL-producing E. coli, the phylogenetic group and sequence type (ST) were determined for both ESBL-producing and dominant E. coli isolates. PFGE profiles were also determined when two types of isolates had the same ST. Among the 345 subjects included, 21 (6%) had ESBL-producing E. coli faecal carriage. None of the previously published risk factors was identified. CTX-M accounted for 86% and SHV-12 for 14%. Dominant and ESBL-producing E. coli were similarly distributed into phylogenetic groups (A, 52%-48%; B1, 5%; B2, 24%-14%; and D, 19%-33%). Dominant and ESBL-producing E. coli displayed a polyclonal structure (18 STs each). However, ST10 and ST131 were identified in dominant and ESBL-producing E. coli isolates from different subjects. Most (20/21) ESBL producers were subdominant and belonged (16/21) to STs different from that of the corresponding dominant E. coli. The 10-fold increase in the rate of healthy subjects with ESBL-producing E. coli faecal carriage over a 5 year period suggests wide dissemination of these isolates in the Parisian community.</abstract><cop>Oxford</cop><pub>Oxford Publishing Limited (England)</pub><doi>10.1093/jac/dks429</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0305-7453 |
ispartof | Journal of antimicrobial chemotherapy, 2013-03, Vol.68 (3), p.562-568 |
issn | 0305-7453 1460-2091 |
language | eng |
recordid | cdi_proquest_miscellaneous_1318695924 |
source | Oxford Journals Online |
subjects | Bacterial infections beta -Lactamase Digestive tract E coli Enzymes Escherichia coli Evolution Feces Inventories Phylogenetics Phylogeny Polyclonal antibodies Risk factors |
title | 10-Fold increase (2006-11) in the rate of healthy subjects with extended-spectrum -lactamase-producing Escherichia coli faecal carriage in a Parisian check-up centre |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T05%3A37%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=10-Fold%20increase%20(2006-11)%20in%20the%20rate%20of%20healthy%20subjects%20with%20extended-spectrum%20%C2%A0-lactamase-producing%20Escherichia%20coli%20faecal%20carriage%20in%20a%20Parisian%20check-up%20centre&rft.jtitle=Journal%20of%20antimicrobial%20chemotherapy&rft.au=Nicolas-Chanoine,%20M.-H.&rft.date=2013-03-01&rft.volume=68&rft.issue=3&rft.spage=562&rft.epage=568&rft.pages=562-568&rft.issn=0305-7453&rft.eissn=1460-2091&rft_id=info:doi/10.1093/jac/dks429&rft_dat=%3Cproquest_cross%3E1318695924%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c222t-b21a4a7c3df5ef2bb887f63fd6624ccd3b984178b1c82386774b14c0ac66dca13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1285277345&rft_id=info:pmid/&rfr_iscdi=true |